Brinton Pharma to expand global R&D lab in UK

Brinton Pharma has decided to invest in a global Research and Development (R&D) centre in the United Kingdom (UK). The company plans to invest GBP 30 million over the next five years to strengthen its product pipelines, create 300 highly skilled jobs and develop innovative products for its global consumers, a company statement notified.

The proposed lifesciences R&D centre in the North of England region of the UK will support the acceleration of the company’s research in the areas of biotechnology, health and lifesciences. The investment helps the company to engage in a thriving lifesciences ecosystem, supporting their global ambitions to build next-generation healthcare products, the statement added.

It said that the company looks towards the UK as a partner to achieve its international aspirations. The UK provides a collaborative business environment which is dedicated to nurture science and innovation with access to some of the finest pharma talent, excellent global connectivity and a broad range of opportunities across the healthcare and lifesciences sector.

Boris Johnson, Prime Minister, the UK, said in the statement, “Trade and investment between the UK and India is creating good jobs and sustaining livelihoods in both of our countries. I’m pleased that Brinton Pharmaceuticals has decided to join the legions of Indian companies investing in the UK, boosting our healthcare sector and driving economic growth.”